Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling.
Ontology highlight
ABSTRACT: The bioflavonoid apigenin has been shown to possess cancer-preventive and anti-cancer activities. In a drug screening, we found that apigenin can inhibit Wnt/β-catenin signaling, a pathway that participates in pivotal biological functions, which dis-regulation results in various human diseases including cancers. However, the underlying mechanism of apigenin in this pathway and its link to anti-cancer activities remain largely unknown. Here we showed that apigenin reduced the amount of total, cytoplasmic, and nuclear β-catenin, leading to the suppression in the β-catenin/TCF-mediated transcriptional activity, the expression of Wnt target genes, and cell proliferation of Wnt-stimulated P19 cells and Wnt-driven colorectal cancer cells. Western blotting and immunofluorescent staining analyses
SUBMITTER: Lin CM
PROVIDER: S-EPMC5428476 | biostudies-literature | 2017 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA